Oculis Holding AG

As of June 30, 2026, Oculis Holding AG carries a market capitalization of 93.84B, placing it among publicly traded companies globally. Its enterprise value stands at 58.67B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Oculis Holding AG's next confirmed earnings release is scheduled for November 5, 2026.

As of June 30, 2026, Oculis Holding AG has 55.53M shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Oculis Holding AG maintains a current ratio of 8.35, meaning it holds 8.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.16, indicating moderate leverage, while an interest coverage ratio of -96.70 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Oculis Holding AG posted a negative return on equity (ROE) of -43.70, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -36.67, reflecting losses generated across the asset base. The company generates approximately - - in revenue per employee across its workforce of 57.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Oculis Holding AG recorded an income tax benefit of -40.66M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -12.38B and -12.34B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Oculis Holding AG's stock has declined approximately 63.50% over the past 52 weeks. The 50-day moving average sits at 1,264.44, while the 200-day moving average is 2,381.42.

Over the twelve months ended June 30, 2026, Oculis Holding AG generated - - in revenue and converted that into -12.34B in net income, yielding earnings per share of -215.94. EBITDA reached -13.33B, while operating income came in at -13.43B.

As of June 30, 2026, Oculis Holding AG holds 35.57B in cash and equivalents against 396.17M in total debt, resulting in a net debt position of -9.60B. Total book value stands at 34.17B, with working capital of 31.96B providing operational flexibility.

Oculis Holding AG produced -10.23B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -28.51M in capital expenditures, free cash flow totaled -10.26B - equivalent to -179.57 per share.

Over the twelve months ended June 30, 2026, Oculis Holding AG paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -10.63: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -21.77, meaning Oculis Holding AG raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Oculis Holding AG has an Altman Z-Score of 9.00, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.